Human Papillomavirus Vaccination for Men: Advancing Policy and Practice

References

• Centers for Disease Control and Prevention . 2012 Sexually transmitted diseases surveillance ( 2012 ). www.cdc.gov/Std/stats12/other.htm#hpv
   Google Scholar
• Giulano AR , PalefskyJM , GoldstoneSet al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males . N. Engl. J. Med.364 ( 5 ), 401 – 411 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Dunne EF , NielsonCM , StoneKM , MarkowitzLE , GiulianoAR . Prevalence of HPV infection among men: a systematic review of the literature . J. Infect. Dis.194 ( 8 ), 1044 – 1057 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Palefsky JM , HollyEA , EfirdcJTet al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men . AIDS19 ( 13 ) 1407 – 1414 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Goldstone S , PalefskyJM , GiulianoARet al. Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men . J. Infect. Dis.203 ( 1 ), 66 – 74 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Nyitray AG , Carvalho da SilvaRJ , BaggioMLet al. Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: the HPV in men (HIM) study . J. Infect. Dis.203 ( 1 ), 49 – 57 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Giuliano AR , Lazcano-PonceE , VillaLLet al. The Human Papillomavirus in Men Study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States . Cancer Epidemiol. Biomarkers Prev.17 ( 8 ), 2036 – 2043 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Hebnes JB1 , OlesenTB , Duun-HenriksenAK , MunkC , NorrildB , KjaerSK . Prevalence of genital human papilloma virus among men in Europe: systematic review and meta-analysis . J. Sex. Med. doi: 10.1111/jsm.12652 ( 2014 ) ( Epub ahead of print ).
   PubMed Web of Science ®Google Scholar
• Vardas E , GiulianoAR , GoldstoneSet al. External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continents . J. Infect. Dis.203 ( 1 ), 58 – 65 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Tobian AAR , Kigozi  , GravittPEet al. Human papillomavirus incidence and clearance among HIV-positive and HIV-negative men in sub-Saharan Africa . AIDS26 , 1555 – 1565 ( 2007 ).
   Google Scholar
• Smith JS , MosesS , HudgensMGet al. Human papillomavirus detection by penile site in young men from Kenya . Sex. Transm. Dis.34 ( 11 ), 928 – 934 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Kreimer AR , BhatiaRK , MesseguerAL , GonzalezP , HerreroR , GiulanoAR . Oral human papillomavirus in health individuals: a systematic review of the literature . Sex. Transm. Dis.37 ( 6 ), 386 – 391 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Gillison ML1 , BroutianT , PickardRKet al. Prevalence of oral HPV infection in the United States, 2009–2010 . JAMA307 ( 7 ), 693 – 703 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kreimer AR , Pierce CampbellCM , LinHYet al. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study . Lancet382 ( 9895 ), 877 – 887 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Beachler DC , WeberKM , MargolickJBet al. Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV negative adults . Cancer Epidemiol. Biomarkers Prev.21 ( 1 ), 122 – 133 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Mooij SH , BootHJ , SpeksnijderAet al. Oral human papillomavirus infection in HIV-negative and HIV-infected MSM . AIDS27 ( 13 ), 2117 – 2128 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Guilano AR , Tortolero-LunaG , FerrerEet al. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions . Vaccine26 ( Suppl. 10 ), K17 – K28 ( 2008 ).
   PubMedGoogle Scholar
• Parkin DM . The global health burden of infection-associated cancers in the year 2002 . Int. J. Cancer118 ( 12 ), 3030 – 3044 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• De Vuyst H , CliffordGM , NascimentoMC , MadeleineMM , FranceschiS . Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis . Int. J. Cancer124 ( 7 ), 1626 – 1636 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Yang Y , Li , X , ZhangZet al. Association of human papillomavirus infection and abnormal anal cytology among HIV-infected MSM in Beijing, China . PLoS ONE7 ( 4 ), e35983 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Bouvard V , BaanR , StraifKet al. A review of human carcinogens – part B: biological agents . Lancet Oncol.10 ( 4 ), 321 – 322 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Jemal A , SimardEP , DorellCet al. Annual report to the nation on the status of cancer, 1975–2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels . J. Natl Cancer Inst.105 , 175 – 201 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• PR Newswire . HPV now the leading cause of oral cancers in the US ( 2011 ). www.prnewswire.com
   Google Scholar
• Reitbergen MM , LeemansCR , BloemenaEet al. Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in The Netherlands as assessed by a validated test algorithm . Int. J. Cancer132 ( 7 ), 1565 – 1571 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Giuliano AR , AnicG , NyitrayAG . Epidemiology and pathology of HPV disease in males . Gynecol. Oncol.117 ( 2 ), S15 – S19 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Frisch M , GlimeliusB , van den BruleAJet al. Sexually transmitted infection as a cause of anal cancer . N. Engl. J. Med.337 ( 19 ), 1350 – 1358 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Malachek DA , GrulichAE , JinF , TempletonDJ , PoyntenIM . The epidemiology and natural history of anal human papillomavirus infection in men who have sex with men . Sex. Health9 ( 6 ), 527 – 537 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Palefsky JM , GiulianoAR , GoldstoneSet al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia . N. Engl. J. Med.365 ( 17 ), 1576 – 1585 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention . Recommendations on the use of quadrivalent human papillomavirus vaccine in males – Advisory Committee on Immunization Practices (ACIP) ( 2011 ). www.cdc.gov
   Google Scholar
• van Aar F , MooijSH , van der SandeMABet al. Anal and penile high-risk human papillomavirus prevalence in HIV-negative and HIV-infected MSM . AIDS27 ( 18 ), 2921 – 2931 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Colón-López V , OrtizAP , Del Toro-MejíasL , ClattsMC , PalefskyJM . Epidemiology of anal HPV infection in high-risk men attending a sexually transmitted infection clinic in Puerto Rico . PLoS ONE9 ( 1 ), e83209 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Stokley S , JeyarajahJ , YankeyDet al. Human papillomavirus vaccination coverage among adolescents, 2007–2013, and postlicensure vaccine safety monitoring, 2006–2014 - United States . MMWR Morb. Mortal. Wkly. Rep.63 ( 29 ), 620 – 624 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Newman PA , LogieCH , DoukasN , AsakuraK . HPV vaccine acceptability among men: a systematic review and meta-analysis . Sex. Transm. Infect.89 ( 7 ), 568 – 574 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Liddon N , HoodJ , WynnBA , MarkowitzMD . Acceptability of human papillomavirus vaccine for males: a review of the literature . J. Adolesc. Health46 ( 2 ), 113 – 123 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Holman DM , BenardV , RolandKB , WatsonM , LiddonN , StokleyS . Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature . JAMA Pediatr.168 ( 1 ), 76 – 82 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Brewer NT , FazekasKI . Predictors of HPV vaccine acceptability: a theory-informed, systematic review . Prev. Med.45 ( 2–3 ), 107 – 114 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Samoff E , DunnA , VandevanterN , BlankS , WeisfuseIB . Predictors of acceptance of hepatitis B vaccination in an urban sexually transmitted diseases clinic . Sex. Transm. Dis.31 ( 7 ), 415 – 420 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Daley MF , HennesseyKA , WeinbaumCMet al. Physician practices regarding adult hepatitis B vaccination: a national survey . Am. J. Prev. Med.36 ( 6 ), 491 – 496 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Brill D . Australia launches national scheme to vaccinate boys against HPV . BMJ346 , f924 ( 2013 ).
   PubMedGoogle Scholar
• Australia Government Department of Health . Human papillomavirus. Immunise Australia Program 2014 ( 2014 ). www.immunise.health.gov.au
   Google Scholar
• National Center for Immunization and Respiratory Diseases . VFC program: vaccines for uninsured children ( 2014 ). www.cdc.gov/features/vfcprogram/
   Google Scholar
• The Henry J. Kaiser Family Foundation . The HPV vaccine: access and use in the U.S. Kaiser Family ( 2014 ). http://kff.org
   Google Scholar
• Beer H , HibbitsS , BrophyS , RahmanMA , WallerJ , ParanjothyS . Does the HPV vaccination programme have implications for cervical screening programmes in the UK?Vaccine32 ( 16 ), 1828 – 1833 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Burger EA , SyS , NygårdM , KristiansenIS , KimJJ . Prevention of HPV-related cancers in Norway: cost–effectiveness of expanding the HPV vaccination program to include pre-adolescent boys . PLoS ONE9 ( 3 ), e89974 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• European Centre of Disease Prevention and Control . Introduction to HPV vaccines in European Union countries – an update . ECDPC, Stockholm ( 2012 ). http://ecdc.europa.eu
   Google Scholar
• Smith MA , CanfellK . Incremental benefits of male HPV vaccination: accounting for inequality in population uptake . PLoS ONE9 ( 8 ), e101048 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Prince Edward Island Canada Department of Health and Wellness . Immunization. Prince Edward Island ( 2014 ). www.gov.pe.ca/health/immunizationschedule
   Google Scholar
• Alberta Health . Human papillomavirus (HPV) vaccine ( 2014 ). www.health.alberta.ca
   Google Scholar
• Teotonio I . Ontario asked to publicly fund HPV vaccine for boys ( 2013 ). www.thestar.com
   Google Scholar
• Luyten J , EngelenB , BeutelsP . The sexual ethics of HPV vaccination for boys . HEC Forum26 ( 1 ), 27 – 42 ( 2014 ).
   PubMedGoogle Scholar
• Brisson M , van de VeldeN , FrancoEL , DroletM , BoilyM . Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunity . J. Infect. D.204 ( 3 ), 372 – 376 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Chesson HW , EkwuemeDU , SaraiyaM , DunneEF , MarkowitzLE . The cost–effectiveness of male HPV vaccination in the United States . Vaccine29 ( 46 ), 8443 – 8459 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Kim JJ , GoldieS . Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States . BMJ229 , b3884 ( 2009 ).
   Google Scholar
• Johnson FR . Moving the QALY forward or just stuck in traffic . Value Health12 ( Suppl. 1 ), S38 – S39 ( 2009 ).
   PubMedGoogle Scholar
• Nord E , DanielsN , KamletM . QALYs: some challenge . Value Health12 ( Suppl. 1 ), S10 – S15 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Stupiansky NW , AlexanderAB , ZimetGD . Human papillomavirus vaccine and men: what are the obstacles and challenge?Curr. Opin. Infect. Dis.25 ( 1 ), 86 – 91 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Foresta C , FerlinA , GarollaA . HPV vaccination: what about male specific HPV related diseases?BMJ339 , b4514 ( 2009 ).
   PubMedGoogle Scholar
• Bresse X , GoergenC , PragerB , JouraE . Universal vaccination with the quadrivalent HPV vaccine in Austria: impact on virus circulation, public health and cost–effectiveness analysis . Expert Rev. Pharmacoecon. Outcomes Res.14 ( 2 ), 269 – 281 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Ali H , DonovanB , WandHet al. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data . BMJ346 ( 1 ), f2032 ( 2013 ).
   PubMedGoogle Scholar
• Tabrizi SN , BrothertonJML , KaldorJMet al. Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study . Lancet Infect. Dis.14 ( 10 ), 958 – 966 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Wilson SE , HarrisT , SethiP , FediurekJ , MacdonaldL , DeeksSL . Coverage from Ontario, Canada’s school-based HPV vaccine program: the first three years . Vaccine31 ( 5 ), 757 – 762 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Potts A , SinkaK , LoveJet al. High uptake of HPV immunisation in Scotland – perspectives on maximising uptake . Euro. Surveill.18 ( 39 ), pii=20593 ( 2013 ).
   Google Scholar
• Sinka K , KavanaghK , GordonRet al. Achieving high and equitable coverage of adolescent HPV vaccine in Scotland . J. Epidemiol. Commun. Health68 ( 1 ), 57 – 63 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Schmidt S , ParsonsHM . Vaccination interest and trends in human papillomavirus vaccine uptake in young adult women aged 18 to 26 years in the United States: an analysis using the 2008–2012 National Health Interview Survey . Am. J. Public Health104 ( 5 ), 946 – 953 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Kessels SJM , MarshallHS , WatsonM , Braunack-MayerAJ , ReuzelR , Tooher , RL . Factors associated with HPV vaccine uptake in teenage girls: a systematic review . Vaccine30 ( 24 ), 3546 – 3556 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kim JJ . Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost–effectiveness modelling analysis . Lancet Infect. Dis.10 ( 12 ), 845 – 852 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Hildesheim A , WacholderS , CatteauG , StruyfF , DubinG , HerreroR . For the CVT Group. Efficacy of the HPV-16/18 vaccine: final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial . Vaccine32 ( 39 ), 5087 – 5097 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Kreimer AR , RodriguezAC , HildesheimAet al. Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine . J. Natl Cancer Inst.103 ( 19 ), 1444 – 1451 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Lazcano-Ponce E , StanleyM , NubiaMuñozet al. Overcoming barriers to HPV vaccination: non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months . Vaccine32 ( 6 ), 725 – 732 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Romanowski B , SchwarzTF , FergusonLMet al. Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination: results from a randomized study . Hum. Vaccin. Immunother.10 ( 5 ), 1155 – 1165 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Dobson SRM , McNeilS , DionneMet al. Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial . JAMA309 ( 17 ), 1793 – 1802 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Herweijer E , LevalA , PlonerAet al. Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma . JAMA311 ( 6 ), 597 – 603 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Kreimer AR , SafaeianM , HildesheimA . Number of human papillomavirus doses and condyloma . JAMA311 ( 23 ), 2439 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Jit M , ChoiYH , LapriseJ-F , BoilyM-C , DroletM , BrissonM . Two-doses strategies for human papillomavirus vaccination: how well do they need to protect?Vaccine32 ( 26 ), 3237 – 3242 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Laprise J-F , DroletM , BoilyM-Cet al. Comparing the cost–effectiveness of two- and three-dose schedules of human papillomavirus vaccination: a transmission-dynamic modelling study . Vaccine32 ( 44 ), 5845 – 5853 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Drolet M , BoilyMC , Van de VeldeN , FrancoEL , BrissonM . Vaccinating girls and boys with different human papillomavirus vaccines: can it optimise population-level effectiveness?PLoS ONE8 ( 6 ), e67072 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Daley MF , HennesseyKA , WeinbaumCMet al. Physician practices regarding adult hepatitis B vaccination: a national survey . Am. J. Prev. Med.36 ( 6 ), 491 – 496 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention . Hepatitis B vaccination coverage among adults – United States, 2004 . MMWR Morb. Mortal. Wkly. Rep.55 , 509 – 511 ( 2006 ).
   PubMedGoogle Scholar
• Rank C , GilbertM , OgilvieGet al. Acceptability of human papillomavirus vaccination and sexual experience prior to disclosure to health care providers among men who have sex with men in Vancouver, Canada; implications for targeted vaccination programs . Vaccine30 ( 39 ), 5755 – 5760 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Cranston RD . Young gay men and the quadrivalent human papillomavirus vaccine – much to gain (and lose) . J. Infect. Dis.209 ( 5 ), 635 – 638 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Carpenter LM , CasperMJ . A tale of two technologies: HPV vaccination, male circumcision, and sexual health . Gender Soc.23 ( 6 ), 790 – 816 ( 2009 ).
   Web of Science ®Google Scholar
• Hull SC , CaplanAL . The case for vaccinating boys against human papillomavirus . Public Health Genomics12 ( 5–6 ), 362 – 327 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Harper DM , AlexanderNM , Ahern , DAet al. Women have a preference for their male partner to be HPV vaccinated . PLoS ONE9 ( 5 ), e97119 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Brankovic I , VerdonkP , KlingeI . Applying a gender lens on human papillomavirus infection: cervical cancer screening, HPV DNA testing, and HPV vaccination . Int. J. Equity Health12 ( 14 ) ( 2013 ).
   PubMedGoogle Scholar
• Baker P , DworkinSL , TongS , BanksI , ShandT , YameyG . The men’s health gap: men must be included in the global health equity agenda ( 2014 ). www.who.int
   Google Scholar
• Hawkes A , BuseK . Gender and global health: evidence, policy, and inconvenient truths . Lancet381 , 1783 – 1787 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services . Immunization and infectious diseases  ( 2014 ). https://www.healthypeople.gov
   Google Scholar
• Shapiro K , SunandaR . Sexual health for people living with HIV . Reprod. Health Matters15 ( Suppl. 29 ), 67 – 92 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Adam , BD , ElliotR , CorriveauP , EnglishK . Impacts of criminalization on the everyday lives of people living with HIV in Canada . Sex. Res. Soc. Policy11 ( 1 ), 39 – 49 ( 2014 ).
   Web of Science ®Google Scholar
• Moodley N , GrayG . Global evidence reaffirms the case for routine HPV and potential HIV adolescent vaccination in South Africa . Future Virol.9 ( 2 ), 207 – 220 ( 2014 ).
   Web of Science ®Google Scholar
• The Scottish Government, Public Health and Wellbeing Directorate . Implementation of immunisation programme: human papillomavirus (HPV) vaccine ( 2007 ). www.sehd.scot.nhs.uk/mels/CEL2007_17.pdf
   Google Scholar
• The Scottish Government, Public Health and Wellbeing Directorate . Implementation of immunisation programme: human papilloma virus (HPV) vaccine–project update including the catch up campaign ( 2008 ). www.sehd.scot.nhs.uk/mels/CEL2008_05.pdf
   Google Scholar
• Kavanagh K , PollockKGJ , PottsAet al. Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types . Br. J. Cancer110 ( 11 ), 2804 – 2811 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Bearman P . Just-so stories: vaccines, autism, and the single-bullet disorder . Soc. Sci. Quart.73 ( 2 ), 112 – 115 ( 2010 ).
   Google Scholar
• McNeil DG Jr . Measles cases in US reach 20 year high . New York Times, 29 May ( 2014 ). www.nytimes.com
   Google Scholar
• Kane MA , SerranoB , De SanjoseS , WittetS . Implementation of human papillomavirus immunization in the developing world . Vaccine30 ( Suppl. 5 ), F102 – F200 ( 2012 ).
   Google Scholar
• Morgan MG , FischhoffB , BostromA , AtmanCJ . Risk Communication: A Mental Models Approach.Cambridge University Press , NY, USA ( 2002 ).
   Google Scholar
• Chakrapani V , NewmanPA , SinghalN , NelsonR , ShunmugamM . “If it’s not working, why would they Be testing it?”: mental models of HIV vaccine trials and preventive misconception among men who have sex with men in India . BMC Public Health13 , 731 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Fu LY , BonhommeL-A , CooperSC , JosephJG , ZimetGD . Educational interventions to increase HPV vaccination acceptance: a systematic review . Vaccine32 ( 16 ), 1901 – 1920 ( 2014 ).
   PubMedGoogle Scholar
• Quadri-Sheriff M , HendrixKS , DownsSM , SturmLA , ZimetGD , FinnellME . The role of herd immunity in parents’ decision to vaccinate children: a systematic review . Pediatrics130 ( 3 ), 522 – 530 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Gerend MA , BarleyJ . Human papillomavirus vaccine acceptability among young adult men . Sex. Transm. Dis.36 ( 1 ), 58 – 62 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Di Clemente RJ , CrosbyRA , SalazarLF , NashR , YoungeS . Is male intent to be vaccinated against HPV a function of the promotion message?Int. J. STD AIDS22 ( 6 ), 332 – 334 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Wegwarth O , Kurzenhäuser-CarstensS , GigerenzerG . Overcoming the knowledge–behavior gap: the effect of evidence-based HPV vaccination leaflets on understanding, intention, and actual vaccination decision . Vaccine32 ( 12 ), 1388 – 1393 ( 2014 ).
   PubMed Web of Science ®Google Scholar